SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
<p><strong>Background</strong> Most studies of immunity to SARS-CoV-2 focus on circulating antibody, giving limited insights into mucosal defences that prevent viral replication and onward transmission. We studied nasal and plasma antibody responses one year after hospitalisation f...
Príomhchruthaitheoirí: | Liew, F, Talwar, S, Cross, A, Willett, BJ, Scott, S, Logan, N, Siggins, MK, Swieboda, D, Sidhu, JK, Efstathiou, C, Moore, SC, Davis, C, Mohamed, N, Nunag, J, King, C, Thompson, AAR, Rowland-Jones, SL, Docherty, AB, Chalmers, JD, Ho, L-P, Horsley, A, Raman, B, Poinasamy, K, Marks, M, Kon, OM, Howard, L, Wootton, DG, Dunachie, S, Quint, JK, Evans, RA, Wain, LV, Fontanella, S, de Silva, TI, Ho, A, Harrison, E, Baillie, JK, Semple, MG, Brightling, C, Thwaites, RS, Turtle, L, Openshaw, PJM |
---|---|
Rannpháirtithe: | ISARIC4C Investigators |
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
Elsevier
2022
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Delayed mucosal antiviral responses despite robust peripheral inflammation in fatal COVID-19
de réir: Sidhu, JK, et al.
Foilsithe / Cruthaithe: (2023) -
Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave
de réir: Read, JM, et al.
Foilsithe / Cruthaithe: (2021) -
Prevalence of Poorly Controlled Asthma and Factors Associated with Specialist Referral in Those with Poorly Controlled Asthma in a Paediatric Asthma Population
de réir: Kallis C, et al.
Foilsithe / Cruthaithe: (2023-10-01) -
No association between exacerbation frequency and stroke in patients with COPD
de réir: Windsor C, et al.
Foilsithe / Cruthaithe: (2016-02-01) -
Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study
de réir: Russell, CD, et al.
Foilsithe / Cruthaithe: (2021)